Zhenyong Li

发表

Occurrence and Risk Factors of Adverse Drug Reactions in Patients Receiving Bivalirudin as Anticoagulant During Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

Zeqi Zheng, Jinlong Li, Lang Hong, 2022, Frontiers in Cardiovascular Medicine.

Bivalirudin Presents a Favorable Safety Profile Regarding Adverse Drug Reactions, Thrombocytopenia, and Bleeding in Chinese Patients With High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Prospective, Multi-Center, Intensive Monitoring Study

Zhaohua Lu, Zheng Ji, C. Luo, 2022, Frontiers in Cardiovascular Medicine.